Skip to main content

Effect of bromelain (ananase®) on human platelet aggregation


Die orale Verabreichung von Bromelain in Form von 2 Ananase®-100-Tabletten an freiwillige Versuchspersonen verminderte bei diesen die Empfänglichkeit für die durch ADP induzierte Aggregation der Blutplättchen.

This is a preview of subscription content, access via your institution.


  1. R. M. Heincke andW. A. Gortner, Econ. Bot.11, 225 (1957).

    Article  Google Scholar 

  2. J. N. Moss, C. V. Frazier andG. S. Martin, Archs. int. Pharmacodyn. Thér.145, 166 (1963).

    CAS  Google Scholar 

  3. R. M. Heinicke, T. Ito, L. McCarthy andM. Yokoyama, Jap. Heart. J., in press.

  4. H. Hayashi, M. Kono, M. Yoshinaga andM. Muto, Int. Symp. Como, Italy 1968. Excerpta med. int. Cong. Ser.188, 34 (1968).

  5. M. Yamakido, N. Oishi andM. Yokoyama, Hawaii med. J.29, 1 (1970).

    Google Scholar 

  6. T. Sano, M. G. J. Boxer, L. A. Boxer andM. Yokoyama, Thromb. Diath. haemorrh.25, 524 (1971).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Additional information

This work was supported by the Honolulu Chamber of Commerce research grants.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Heinicke, R.M., van der Wal, L. & Yokoyama, M. Effect of bromelain (ananase®) on human platelet aggregation. Experientia 28, 844–845 (1972).

Download citation

  • Published:

  • Issue Date:

  • DOI:


  • Platelet Aggregation
  • Platelet Rich Plasma
  • Blood Platelet
  • Rabbit Platelet
  • Volunteer Blood Donor